Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter M Brooks

Showing results (31-40 of 53) with videos related to

Pageof 6
Sort By:
The Journal of Rheumatology|September 10, 2009
Observations from the OMERACT Drug Safety Summit, May 2008Lee S Simon, C Vibeke Strand, Maarten Boers, et al.
Chronic Illness|December 13, 2006
Selection of patients for inpatient rehabilitation or direct home discharge following total joint replacement surgery: a comparison of health status and out-of-pocket expenditure of patients undergoing hip and knee arthroplasty for osteoarthritisKate L Tribe, Helen M Lapsley, Marita J Cross, et al.
The Journal of Rheumatology|August 3, 2019
IntroductionLyn March, Bethan Richards, Michael Gill, et al.
The Journal of Rheumatology|November 3, 2005
Attributes and skills of an effective musculoskeletal consumerPeter S Tugwell, Andrew J Wilson, Peter M Brooks, et al.
The Journal of Rheumatology|October 6, 2005
Challenges and progress in adverse event ascertainment and reporting in clinical trialsMarissa N D Lassere, Kent R Johnson, Thasia G Woodworth, et al.
The Journal of Rheumatology|June 7, 2007
Development of the effective musculoskeletal consumer scaleElizabeth Kristjansson, Peter S Tugwell, Andrew J Wilson, et al.
The Journal of Rheumatology|March 4, 2014
How to choose core outcome measurement sets for clinical trials: OMERACT 11 approves filter 2.0Maarten Boers, John R Kirwan, Laure Gossec, et al.
The Journal of Rheumatology|October 17, 2016
Developing an OMERACT Core Outcome Set for Assessing Safety Components in Rheumatology Trials: The OMERACT Safety Working GroupLouise Klokker, Peter Tugwell, Daniel E Furst, et al.
The Journal of Rheumatology|September 10, 2009
Responsiveness of the Effective Consumer Scale (EC-17)Nancy Santesso, Tamara Rader, George A Wells, et al.
The Journal of Rheumatology|October 6, 2005
Standardized assessment of adverse events in rheumatology clinical trials: summary of the OMERACT 7 drug safety module updateMarissa N D Lassere, Kent R Johnson, Maarten Boers, et al.
Pageof 6

Showing results (31-40 of 53) with videos related to

Sort By:
Pageof 6
The Journal of Rheumatology|September 10, 2009
Observations from the OMERACT Drug Safety Summit, May 2008Lee S Simon, C Vibeke Strand, Maarten Boers, et al.
Chronic Illness|December 13, 2006
Selection of patients for inpatient rehabilitation or direct home discharge following total joint replacement surgery: a comparison of health status and out-of-pocket expenditure of patients undergoing hip and knee arthroplasty for osteoarthritisKate L Tribe, Helen M Lapsley, Marita J Cross, et al.
The Journal of Rheumatology|August 3, 2019
IntroductionLyn March, Bethan Richards, Michael Gill, et al.
The Journal of Rheumatology|November 3, 2005
Attributes and skills of an effective musculoskeletal consumerPeter S Tugwell, Andrew J Wilson, Peter M Brooks, et al.
The Journal of Rheumatology|October 6, 2005
Challenges and progress in adverse event ascertainment and reporting in clinical trialsMarissa N D Lassere, Kent R Johnson, Thasia G Woodworth, et al.
The Journal of Rheumatology|June 7, 2007
Development of the effective musculoskeletal consumer scaleElizabeth Kristjansson, Peter S Tugwell, Andrew J Wilson, et al.
The Journal of Rheumatology|March 4, 2014
How to choose core outcome measurement sets for clinical trials: OMERACT 11 approves filter 2.0Maarten Boers, John R Kirwan, Laure Gossec, et al.
The Journal of Rheumatology|October 17, 2016
Developing an OMERACT Core Outcome Set for Assessing Safety Components in Rheumatology Trials: The OMERACT Safety Working GroupLouise Klokker, Peter Tugwell, Daniel E Furst, et al.
The Journal of Rheumatology|September 10, 2009
Responsiveness of the Effective Consumer Scale (EC-17)Nancy Santesso, Tamara Rader, George A Wells, et al.
The Journal of Rheumatology|October 6, 2005
Standardized assessment of adverse events in rheumatology clinical trials: summary of the OMERACT 7 drug safety module updateMarissa N D Lassere, Kent R Johnson, Maarten Boers, et al.
Pageof 6